- Presentations
- 2
- Markets
- 1
Truqap is a brand of Capivasertib marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Capivasertib
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 160 mg tablet, 200 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Truqap 160 mg tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Truqap 200 mg tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Truqap
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.